Litcius/Paper detail

Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

Mead, S, Khalili-Shirazi, A, Potter, C, Mok, T, Nihat, A, Hyare, H, Canning, S, Schmidt, C, Campbell, T, Darwent, L, Muirhead, N, Ebsworth, N, Hextall, P, Wakeling, M, Linehan, J, Libri, V, Williams, B, Jaunmuktane, Z, Brandner, S, Rudge, P, Collinge, J

2022UCL Discovery (University College London)85 citations

Topics & Concepts

MedicinePRNPDiseaseMonoclonal antibodyAdverse effectCohortInternal medicineAntibodyPrion proteinVirologyImmunologyPrion Diseases and Protein Misfolding
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme | Litcius